Biosimilars and Novel Insulins.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001079
Abstract: BACKGROUND Insulin therapy is the mainstay of treatment for type 1 diabetes and may be necessary in type 2 diabetes. Current insulin analogues present a more physiological profile, are effective, and with less risk of… read more here.
Keywords: biosimilar insulins; insulin; insulin aspart; faster aspart ... See more keywords
Introduction of biosimilar insulins in Europe
Sign Up to like & getrecommendations! Published in 2017 at "Diabetic Medicine"
DOI: 10.1111/dme.13400
Abstract: Regulatory approval of the first biosimilar insulin in Europe, LY2963016 insulin glargine (Abasaglar®), in 2014 expanded the treatment options available to people with diabetes. As biosimilar insulin products come to market, it is important to… read more here.
Keywords: insulin; insulins europe; insulin glargine; biosimilar insulin ... See more keywords